Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Sphingolipids [SP] (W) --> Neutral glycosphingolipids [SP05]--> Galβ1-4GlcNAcβ1-3Galβ1-4Glc- (Neolacto series) [SP0505]
LM_IDCommon NameSystematic NameFormulaMass
LMSP0505AA00paragloboside, nLc4CerGalβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer--
LMSP0505AA01-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/16:0)
C60H110N2O231226.7499
LMSP0505AA02-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/18:0)
C62H114N2O231254.7812
LMSP0505AA03-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/20:0)
C64H118N2O231282.8125
LMSP0505AA04-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/22:0)
C66H122N2O231310.8438
LMSP0505AA05-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:0)
C68H126N2O231338.8751
LMSP0505AA06-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:0)
C70H130N2O231366.9064
LMSP0505AA07-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:1(15Z))
C68H124N2O231336.8595
LMSP0505AA08-Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:1(17Z))
C70H128N2O231364.8908
LMSP0505AB00X-hapten, SSEA-1, Lex-5Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer
--
LMSP0505AB01-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/16:0)
C66H120N2O271372.8079
LMSP0505AB02-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/18:0)
C68H124N2O271400.8392
LMSP0505AB03-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/20:0)
C70H128N2O271428.8705
LMSP0505AB04-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/22:0)
C72H132N2O271456.9018
LMSP0505AB05-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:0)
C74H136N2O271484.9331
LMSP0505AB06-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:0)
C76H140N2O271512.9644
LMSP0505AB07-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:1(15Z))
C74H134N2O271482.9174
LMSP0505AB08-Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:1(17Z))
C76H138N2O271510.9487
LMSP0505AC00-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer--
LMSP0505AC01-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/16:0)
C66H120N2O281388.8028
LMSP0505AC02-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/18:0)
C68H124N2O281416.8341
LMSP0505AC03-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/20:0)
C70H128N2O281444.8654
LMSP0505AC04-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/22:0)
C72H132N2O281472.8967
LMSP0505AC05-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:0)
C74H136N2O281500.9280
LMSP0505AC06-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:0)
C76H140N2O281528.9593
LMSP0505AC07-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:1(15Z))
C74H134N2O281498.9123
LMSP0505AC08-Galα1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:1(17Z))
C76H138N2O281526.9436
LMSP0505AD00H1 glycolipid, type II antigenFucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-Cer--
LMSP0505AD01-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/16:0)
C66H120N2O271372.8079
LMSP0505AD02-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/18:0)
C68H124N2O271400.8392
LMSP0505AD03-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/20:0)
C70H128N2O271428.8705
LMSP0505AD04-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/22:0)
C72H132N2O271456.9018
LMSP0505AD05-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:0)
C74H136N2O271484.9331
LMSP0505AD06-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:0)
C76H140N2O271512.9644
LMSP0505AD07-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/24:1(15Z))
C74H134N2O271482.9174
LMSP0505AD08-Fucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ-
Cer(d18:1/26:1(17Z))
C76H138N2O271510.9487
LMSP0505AE00type II B antigenGalα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer
--
LMSP0505AE01-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/16:0)
C72H130N2O321534.8607
LMSP0505AE02-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/18:0)
C74H134N2O321562.8920
LMSP0505AE03-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/20:0)
C76H138N2O321590.9233
LMSP0505AE04-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/22:0)
C78H142N2O321618.9546
LMSP0505AE05-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/24:0)
C80H146N2O321646.9859
LMSP0505AE06-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/26:0)
C82H150N2O321675.0172
LMSP0505AE07-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/24:1(15Z))
C80H144N2O321644.9702
LMSP0505AE08-Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-3Galβ1-
4Glcβ-Cer(d18:1/26:1(17Z))
C82H148N2O321673.0015
LMSP0505AF00type II A antigenGalNAcβ1-3(Fucα1-2)Galβ1-4GlcNAcβ1-
3Galβ1-4Glcβ-Cer
--
LMSP0505AF01-GalNAcβ1-3(Fucα1-2)Galβ1-4GlcNAcβ1-
3Galβ1-4Glcβ-Cer(d18:1/16:0)
C74H133N3O321575.8872
LMSP0505AF02-GalNAcβ1-3(Fucα1-2)Galβ1-4GlcNAcβ1-
3Galβ1-4Glcβ-Cer(d18:1/18:0)
C76H137N3O321603.9185
LMSP0505AF03-GalNAcβ1-3(Fucα1-2)Galβ1-4GlcNAcβ1-
3Galβ1-4Glcβ-Cer(d18:1/20:0)
C78H141N3O321631.9498
LMSP0505AF04-GalNAcβ1-3(Fucα1-2)Galβ1-4GlcNAcβ1-
3Galβ1-4Glcβ-Cer(d18:1/22:0)
C80H145N3O321659.9811

Showing page 1 of 20     Results:    1  2  3  4  5  Next  Last     Showing results 1 to 50 of 995

   

logo LIPID MAPS is funded by a Wellcome Trust.